Pricing Log in Create free account

Ardelyx, Inc. (ARDX) vs Sagimet Biosciences Inc. (SGMT)

Ardelyx, Inc. and Sagimet Biosciences Inc. are both Biotechnology companies. Ardelyx, Inc. and Sagimet Biosciences Inc. are of similar size ($802.6M and $786.8M). Sagimet Biosciences Inc. has the higher net margin (0.00% vs −11.9%) and the lower return on invested capital (−205.2% vs −17.2%). Across the 14 metrics below, Sagimet Biosciences Inc. leads on 8 and Ardelyx, Inc. on 6.

Valuation

Metric ARDX SGMT Biotechnology median
P/E n/m n/m 11.58
P/S 1.68 n/m 9.61
P/B 4.79 2.35 2.26
Price to free cash flow n/m n/m 26.41
EV/EBITDA n/m n/m 0.72
EV/Sales 1.66 n/m 9.43
Earnings yield (7.10%) (11.30%) (32.28%)
Free cash flow yield (2.03%) (6.93%) (22.27%)

Profitability

Metric ARDX SGMT Biotechnology median
Gross margin 94.46% 0.00% 68.81%
Operating margin (7.71%) 0.00% 0.00%
Net margin (11.85%) 0.00% 0.00%
Free cash flow margin (3.41%) 0.00% 0.00%
Return on equity (34.85%) (24.37%) (50.30%)
Return on assets (10.33%) (23.49%) (45.47%)
Return on invested capital (17.21%) (205.24%) 0.00%

Growth

Metric ARDX SGMT Biotechnology median
Revenue growth (TTM) 17.57% — 6.78%
EPS growth (last fiscal year) (52.94%) (8.97%) 29.88%
Revenue growth, 5-year CAGR 121.90% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ARDX SGMT Biotechnology median
Debt to equity 1.54 0.00 0.00
Current ratio 3.45 45.02 4.74
Net debt to EBITDA 1.63 1.98 1.01

Dividend

Metric ARDX SGMT Biotechnology median
Dividend yield — — 0.39%
Payout ratio — — —

Size

Metric ARDX SGMT Biotechnology median
Market cap 786.79m 802.59m 168.63m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack